Measuring skin elasticity in Wilson's disease patients on D-Penicillamine
Part of Brain & nervous system, Digestive system, Genetic & congenital, Hormones & metabolism clinical trials.
This study checks if D-Penicillamine, a treatment for Wilson's disease, causes skin damage by measuring skin elasticity on the forearm and cheek. It compares results between patients taking the drug and healthy volunteers matched by age and sex.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have Wilson's disease confirmed by a genetic test
- You are 12 years old or older
- You are being treated with D-Penicillamine
- You have no other known condition that affects skin elasticity
- You do not have skin lesions or active treatments on your forearm or cheek
- You are not pregnant or breastfeeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how copper levels in urine change throughout the day and night in people with Wilson disease. If you take part, you will collect all your urine for 24 hours so researchers can measure copper at different times.
This study compares oral (mouth and teeth) health in people with Wilson’s disease versus people without it. It aims to see whether Wilson’s disease is linked to specific dental and imaging findings, which could help with future prevention and care.
This study follows people who already have Wilson disease to understand how the condition changes over time. It may help researchers better predict future symptoms and improve care.
This study tests an injection called LY-M003 for people with Wilson disease who have already been treated with standard medicines. The goal is to see if it is safe and works for them.
This study looks at how Wilson's disease affects the kidneys. It aims to better understand kidney problems in people with Wilson's disease, which could help improve care.
This study tests a sensor device called ADHELASKIN to see if it can accurately measure skin damage in people with systemic sclerosis (SSc), a condition that hardens and tightens the skin. The goal is to find a better way to track skin changes during the disease.
Hear when a new Wilson Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.